In International Innovation, Dr. David Lanar talks about his part in research to prevent infection by the wily parasites that cause malaria.
The malaria parasite defends itself from the immune system by making its surface proteins less recognizable, allowing the parasite to evade detection
and hide itself away until it replicates and causes serious infection. This breakthrough research allows many copies of these proteins to be fully
displayed over the surface of a nanoparticle that is given as part of a new malaria vaccine. Immune cells can uptake and process the nanoparticle
resulting in a protective immune response that can then prevent infection by invading live parasites.
Dr. Lanar works with Dr. Peter Burkhard of the University of Connecticut through a cooperative research and development agreement between their respective organizations.
Their research is funded by the National Institutes of Health and the US Military Infectious Diseases Research Program at the US Army Medical Research and Materiel Command (USAMRMC).
Click here for the full International Innovation story on page 39 -- http://www.research-europe.com/magazine/ISSUE/129/index.html .